301 related articles for article (PubMed ID: 17569404)
41. Ciclopirox gel for seborrheic dermatitis of the scalp.
Aly R; Katz HI; Kempers SE; Lookingbill DP; Lowe N; Menter A; Morman M; Savin RC; Wortzman M
Int J Dermatol; 2003 Sep; 42 Suppl 1():19-22. PubMed ID: 12895183
[TBL] [Abstract][Full Text] [Related]
42. Cost-effectiveness evaluation of clobetasol propionate shampoo (CPS) maintenance in patients with moderate scalp psoriasis: a Pan-European analysis.
Papp K; Poulin Y; Barber K; Lynde C; Prinz JC; Berg M; Kerrouche N; Rives VP
J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1407-14. PubMed ID: 22032474
[TBL] [Abstract][Full Text] [Related]
43. A double-blind, placebo-controlled pilot study to estimate the efficacy and tolerability of a nonsteroidal cream for the treatment of cradle cap (seborrheic dermatitis).
David E; Tanuos H; Sullivan T; Yan A; Kircik LH
J Drugs Dermatol; 2013 Apr; 12(4):448-52. PubMed ID: 23652893
[TBL] [Abstract][Full Text] [Related]
44. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.
Lebwohl M; Sherer D; Washenik K; Krueger GG; Menter A; Koo J; Feldman SR
Int J Dermatol; 2002 May; 41(5):269-74. PubMed ID: 12100701
[TBL] [Abstract][Full Text] [Related]
45. Treatment of seborrhoeic dermatitis of the scalp with a topical solution of urea, lactic acid, and propylene glycol (K301): results of two double-blind, randomised, placebo-controlled studies.
Emtestam L; Svensson Å; Rensfeldt K
Mycoses; 2012 Sep; 55(5):393-403. PubMed ID: 21966947
[TBL] [Abstract][Full Text] [Related]
46. Maintenance effect of a once-weekly regimen of a Selenium Disulfide-based shampoo in moderate-to-severe scalp seborrheic dermatitis after initial treatment with topical corticosteroid/salicylic acid.
Massiot P; Reygagne P; Chagnoleau C; Kanoun-Copy L; Pouradier F; Loussouarn G; Queille-Roussel C; Jouni H; Kerob D
Eur J Dermatol; 2023 Mar; 33(S1):13-18. PubMed ID: 37098774
[TBL] [Abstract][Full Text] [Related]
47. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
48. A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis.
Olsen EA; Cram DL; Ellis CN; Hickman JG; Jacobson C; Jenkins EE; Lasser AE; Lebwohl M; Leibsohn E; Medansky RS
J Am Acad Dermatol; 1991 Mar; 24(3):443-7. PubMed ID: 2061442
[TBL] [Abstract][Full Text] [Related]
49. Medicated shampoos for the treatment of seborrheic dermatitis.
Waldroup W; Scheinfeld N
J Drugs Dermatol; 2008 Jul; 7(7):699-703. PubMed ID: 18664167
[TBL] [Abstract][Full Text] [Related]
50. Treatment of dandruff with 5% tea tree oil shampoo.
Satchell AC; Saurajen A; Bell C; Barnetson RS
J Am Acad Dermatol; 2002 Dec; 47(6):852-5. PubMed ID: 12451368
[TBL] [Abstract][Full Text] [Related]
51. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
52. Treatment of mild-to-moderate chronic hand dermatitis with clobetasol propionate 0.05% EF foam: results from an open-label study.
Kircik LH; Tropmann C
J Drugs Dermatol; 2011 Dec; 10(12):1398-402. PubMed ID: 22134563
[TBL] [Abstract][Full Text] [Related]
53. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
Menter A
Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
[TBL] [Abstract][Full Text] [Related]
54. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream.
Breneman D; Fleischer AB; Kaplan D; Lebwohl M; Miller B; Pariser D; Rist T; Swinyer L; Liu Y; Foley V
J Drugs Dermatol; 2005; 4(3):330-6. PubMed ID: 15898289
[TBL] [Abstract][Full Text] [Related]
55. Impact of clobetasol propionate 0.05% spray on health-related quality of life in patients with plaque psoriasis.
Menter MA; Caveney SW; Gottschalk RW
J Drugs Dermatol; 2012 Nov; 11(11):1348-54. PubMed ID: 23135087
[TBL] [Abstract][Full Text] [Related]
56. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of Iralfaris shampoo in the treatment of scalp psoriasis: a videodermoscopy evaluation prospective study in 70 patients.
Rossi A; Pranteda G; Iorio A; Mari E; Milani M
G Ital Dermatol Venereol; 2012 Dec; 147(6):625-30. PubMed ID: 23149708
[TBL] [Abstract][Full Text] [Related]
58. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.
Gottlieb AB; Ford RO; Spellman MC
J Cutan Med Surg; 2003; 7(3):185-92. PubMed ID: 12704534
[TBL] [Abstract][Full Text] [Related]
59. Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis.
Swinyer LJ; Decroix J; Langner A; Quiring JN; Blockhuys S
Cutis; 2007 Jun; 79(6):475-82. PubMed ID: 17713152
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff.
Schmidt-Rose T; Braren S; Fölster H; Hillemann T; Oltrogge B; Philipp P; Weets G; Fey S
Int J Cosmet Sci; 2011 Jun; 33(3):276-82. PubMed ID: 21272039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
